Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference42 articles.
1. Wehrli W. Rifampin: Mechanisms of action and resistance, reviews of infectious diseases. Rev Infect Dis. 1983;5(3):S407–11.
2. Hussain A, Altamimi MA, Alshehri S, Imam SS, Shakeel F, Singh SK. Novel approach for transdermal delivery of rifampicin to induce synergistic antimycobacterial effects against cutaneous and systemic tuberculosis using a cationic nanoemulsion gel. Int J Nanomedicine. 2020;15:1073–94.
3. Thakur BK, Verma S, Hazarika DA. Clinicopathological study of cutaneous tuberculosis at Dibrugarh district, Assam. Indian J Dermatol. 2012;57:63–5.
4. Begum K, Shahid MS, Jalil R. Topical nanoemulsion of rifampicin with benzoic acid and salicylic acid: activity against staphylococcus aureus, stap. epidermis and candida albicans, Bangladesh. Pharm J. 2019;22:1–6.
5. Caon T, Campos CEM, Simões CMO, Silva MAS. Novel perspectives in the tuberculosis treatment: administration of isoniazid through the skin. Int J Pharm. 2015;494:463–70.